HOPE PHARMA SOLUTIONS LTD

Company Registration Number:
09734961 (England and Wales)

Unaudited abridged accounts for the year ended 31 August 2023

Period of accounts

Start date: 01 September 2022

End date: 31 August 2023

HOPE PHARMA SOLUTIONS LTD

Contents of the Financial Statements

for the Period Ended 31 August 2023

Balance sheet
Notes

HOPE PHARMA SOLUTIONS LTD

Balance sheet

As at 31 August 2023


Notes

2023

2022


£

£
Fixed assets
Tangible assets: 3 190,077 255,489
Total fixed assets: 190,077 255,489
Current assets
Stocks: 166,504 106,500
Debtors:   56,253
Cash at bank and in hand: 253,750 355,562
Total current assets: 476,507 462,062
Creditors: amounts falling due within one year:   (92,764) (102,500)
Net current assets (liabilities): 383,743 359,562
Total assets less current liabilities: 573,820 615,051
Creditors: amounts falling due after more than one year:   (25,000) (35,000)
Provision for liabilities: (35,780) (24,525)
Total net assets (liabilities): 513,040 555,526
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 513,039 555,525
Shareholders funds: 513,040 555,526

The notes form part of these financial statements

HOPE PHARMA SOLUTIONS LTD

Balance sheet statements

For the year ending 31 August 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 30 April 2024
and signed on behalf of the board by:

Name: Ireti Blankson
Status: Director

The notes form part of these financial statements

HOPE PHARMA SOLUTIONS LTD

Notes to the Financial Statements

for the Period Ended 31 August 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

HOPE PHARMA SOLUTIONS LTD

Notes to the Financial Statements

for the Period Ended 31 August 2023

2. Employees

2023 2022
Average number of employees during the period 9 25

HOPE PHARMA SOLUTIONS LTD

Notes to the Financial Statements

for the Period Ended 31 August 2023

3. Tangible Assets

Total
Cost £
At 01 September 2022 351,513
At 31 August 2023 351,513
Depreciation
At 01 September 2022 96,024
Charge for year 65,412
At 31 August 2023 161,436
Net book value
At 31 August 2023 190,077
At 31 August 2022 255,489